FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.3318
-0.0094 (-2.75%)
At close: Jan 30, 2026, 4:00 PM EST
0.3479
+0.0161 (4.85%)
After-hours: Jan 30, 2026, 7:55 PM EST
FibroBiologics Employees
FibroBiologics had 13 employees as of December 31, 2024. The number of employees increased by 3 or 30.00% compared to the previous year.
Employees
13
Change (1Y)
3
Growth (1Y)
30.00%
Revenue / Employee
n/a
Profits / Employee
-$1,423,154
Market Cap
22.07M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Sep 30, 2023 | 8 | 1 | 14.29% |
| Jun 30, 2023 | 7 | - | - |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CASI Pharmaceuticals | 233 |
| IO Biotech | 78 |
| Vistagen Therapeutics | 59 |
| CollPlant Biotechnologies | 57 |
| IN8bio | 17 |
| Genenta Science | 13 |
| Neuphoria Therapeutics | 8 |
| Intensity Therapeutics | 7 |
FBLG News
- 11 days ago - FibroBiologics to Present at the DealFlow Discovery Conference - GlobeNewsWire
- 24 days ago - FibroBiologics CEO Issues Letter to Shareholders - GlobeNewsWire
- 25 days ago - FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference - GlobeNewsWire
- 26 days ago - FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease - GlobeNewsWire
- 4 weeks ago - FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis - GlobeNewsWire
- 6 weeks ago - FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 6 weeks ago - FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 7 weeks ago - FibroBiologics Files New Patent For Fibroblast Tech To Advance Deeper Into Orthopedics - Benzinga